---
title: "Methylclothiazide - Hypertensive Disorder - 2"
sidebar: mydoc_sidebar
permalink: db00232-mesh-d006973-2.html
toc: false 
---


Path ID: `DB00232_MESH_D006973_2`
{% include image.html url="images/db00232-mesh-d006973-2.png" file="db00232-mesh-d006973-2.png" alt="db00232-mesh-d006973-2" %}

## Concepts

|------------|------|---------|
| Identifier | Name | Type    |
|------------|------|---------|
| MESH:D008736 | Methylclothiazide | Drug |
| GO:0004089 | Carbonate dehydratase activity | MolecularActivity |
| GO:0042310 | Vasoconstriction | BiologicalProcess |
| MESH:D006973 | Hypertensive disorder | Disease |
|------------|------|---------|

## Relationships

|---------|-----------|---------|
| Subject | Predicate | Object  |
|---------|-----------|---------|
| Methylclothiazide | NEGATIVELY REGULATES | Carbonate Dehydratase Activity |
| Carbonate Dehydratase Activity | POSITIVELY CORRELATED WITH | Vasoconstriction |
| Vasoconstriction | POSITIVELY CORRELATED WITH | Hypertensive Disorder |
|---------|-----------|---------|

Comment: The antihypertensive mechanism of methyclothiazide is not well understood. At low doses methylclothiazide can inhibit carbonic anhydrase.

Reference: 
  - [https://pubmed.ncbi.nlm.nih.gov/25079851/](https://pubmed.ncbi.nlm.nih.gov/25079851/)
  - [https://go.drugbank.com/drugs/DB00232](https://go.drugbank.com/drugs/DB00232)
